Dr. Andrew Cluster, M.D.
Claim this profileWashington University School of Medicine
Studies Brain Tumor
Studies Cerebral Gliomas
17 reported clinical trials
28 drugs studied
About Andrew Cluster, M.D.
Education:
- Received an MD from Washington University School of Medicine.
Experience:
- Serves as a Pediatric Oncologist at Washington University Physicians, specializing in oncology and pediatric cancer.
- Affiliated with St. Louis Children's Hospital, recognized as a leading pediatric hospital.
- Active member of the Siteman Cancer Center, focusing on innovative pediatric cancer treatments and clinical trials.
- Engaged in the Cancer Predisposition Program to identify and monitor genetically at-risk children.
- Collaborates across multiple specialties including the Melanoma and Nevus Clinic, Stem Cell Transplant and Cellular Therapy Program, and Brain Tumor and Neuro-Oncology Program.
Area of expertise
1Brain Tumor
Stage I
Stage II
NTRK positive
2Cerebral Gliomas
Stage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Andrew Cluster, M.D. is currently running
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
ONC201
for Brain Tumor
This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with ONC201 following frontline radiotherapy will extend overall survival and progression-free survival in this population. Eligible participants will have histologically diagnosed H3 K27M-mutant diffuse glioma and have completed standard frontline radiotherapy.
Recruiting1 award Phase 3
More about Andrew Cluster, M.D.
Clinical Trial Related5 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Andrew Cluster, M.D. has experience with
- Radiation Therapy
- ONC201
- Selumetinib
- Cyclophosphamide
- Lomustine
- Vincristine
Breakdown of trials Andrew Cluster, M.D. has run
Brain Tumor
Cerebral Gliomas
Brain Cancer
Fibrillary Astrocytoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Cluster, M.D. specialize in?
Andrew Cluster, M.D. focuses on Brain Tumor and Cerebral Gliomas. In particular, much of their work with Brain Tumor has involved Stage I patients, or patients who are Stage II.
Is Andrew Cluster, M.D. currently recruiting for clinical trials?
Yes, Andrew Cluster, M.D. is currently recruiting for 9 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Andrew Cluster, M.D. has studied deeply?
Yes, Andrew Cluster, M.D. has studied treatments such as Radiation Therapy, ONC201, Selumetinib.
What is the best way to schedule an appointment with Andrew Cluster, M.D.?
Apply for one of the trials that Andrew Cluster, M.D. is conducting.
What is the office address of Andrew Cluster, M.D.?
The office of Andrew Cluster, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.